Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal ... higher-growth healthcare sectors such as cancer care, gastroenterology, and at-home healthcare solutions.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Cramer recommended the questioner to buy Cardinal Health ... We believe valuations of health care companies like CAH that focus on cost optimization and promote technological efficiency across ...

India’s most prominent cardinal is standing down as Archbishop of Bombay, have reached the ago of 80 right before last ...

West Virginia’s health care system is under the weight of inefficiency, leaving many rural communities without access to ...

Cardinal Health, Inc. operates as a healthcare services ... nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

Re-Segmenting Cardinal Health’s Business Cardinal Health has ... “We’ve worked to position robots as complements to human jobs, which has helped ease concerns.” The integration of data ...

Cardinal Health CEO Jason Hollar recounted the ... its profitable business delivering medical supplies for at-home care. Altogether the four acquisitions in 2024 total $6.2 billion.

The U.S. Environmental Protection Agency (EPA) awarded the city of Madison a $20 million grant on Jan. 8 aimed to enhance ...